1 of 1
Story summary
- L'Oréal will increase its stake in Galderma to 20% by acquiring an additional 10% from a consortium led by EQT.
- The transaction is valued at approximately 3.9 billion Swiss francs ($4.9 billion).
- The deal is expected to close by the first quarter of 2026, pending regulatory approval.
- Galderma will remain independent under Chief Executive Officer Flemming Ørnskov.
- The companies may appoint two L'Oréal representatives to Galderma's board.
